CANbridge ×
Edit

CANbridge ×

http://www.canbridgepharma.com/
Last activity: 16.10.2023
Categories: LifeMedTechProductSpecialtyBioTechDevelopmentHealthTech
CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.
Website visits
8K /mo.
Mentions
18
Location: China, Beijing
Employees: 11-50
Total raised: $176M
Founded date: 2012

Investors 5

Funding Rounds 4

DateSeriesAmountInvestors
05.12.2020Series E$43M-
18.02.2020Series D$98MGeneral At...
23.05.2017Series B$25M-
02.12.2014Series A$10M-

Mentions in press and media 18

DateTitleDescriptionSource
16.10.2023CANbridge Announces Full Enrollment Reached in the Core Part...BEIJING and BURLINGTON, Mass., Oct. 16, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals Inc. (1228.HK...en.prnasia...
09.10.2023CANbridge Announces Marketing Approval of CAN108 (/LIVMARLI®...LIVMARLI is the First and Only Treatment Approved in Taiwan for Cholestatic Pruritus in ALGS LIVMARL...en.prnasia...
06.09.2023CANbridge to Participate in Two Investor Conferences in Sept...BEIJING and BURLINGTON, Mass., Sept. 6, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals Inc. (HKEX:12...en.prnasia...
31.08.2023CANbridge Announces Interim Financial Results and Corporate ...BEIJING and CAMBRIDGE, Mass., Aug. 31, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals, Inc. ("C...en.prnasia...
25.02.2021CANbridge Pharmaceuticals and Puma Biotechnology Agree to Te...BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 25, 2021-- CANbridge Pharmaceuticals, Inc., a ...oaoa.com/n...
05.12.2020CANbridge Pharmaceuticals Completes $43 Million Series E Fin...-qimingvc.c...
01.12.2020CANbridge Pharmaceuticals Closes $43 Million Series E Financ...BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals Inc., a company developin...citybizlis...
19.02.2020Canbridge nabs $98M to develop rare disease treatmentsChinese drugmaker Canbridge Pharmaceuticals has raised $98 million in a Series D led by General Atla...pitchbook....
18.02.2020CANbridge Pharmaceuticals Completes US$98 Million Series D F...-generalatl...
18.02.2020CANbridge Pharmaceuticals Closes US$98M Series D FinancingCANbridge Pharmaceuticals Inc., a Beijing, China-based biopharmaceutical company developing innovati...finsmes.co...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In